146 related articles for article (PubMed ID: 10735934)
1. Hereditary prostate cancer.
Bratt O
BJU Int; 2000 Mar; 85(5):588-98. PubMed ID: 10735934
[No Abstract] [Full Text] [Related]
2. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
3. BRCA2 mutation in a family with hereditary prostate cancer.
Grönberg H; Ahman AK; Emanuelsson M; Bergh A; Damber JE; Borg A
Genes Chromosomes Cancer; 2001 Mar; 30(3):299-301. PubMed ID: 11170288
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid hormones and genetic susceptibility to breast and prostate cancer.
Feigelson HS; Ross RK; Yu MC; Coetzee GA; Reichardt JK; Henderson BE
Drug Metab Rev; 1998 May; 30(2):421-34. PubMed ID: 9606611
[No Abstract] [Full Text] [Related]
5. Hereditary breast cancer.
Holli K
Acta Oncol; 1999; 38 Suppl 13():29-32. PubMed ID: 10612493
[TBL] [Abstract][Full Text] [Related]
6. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
7. BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.
Gilbert F; Dabney MK; Diemer K; Ludwig S; Rosenthal G; Osborne MP
Ann N Y Acad Sci; 1997 Dec; 833():198-203. PubMed ID: 9616755
[No Abstract] [Full Text] [Related]
8. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
9. Complex decision-making for BRCA1/2 carriers.
Matloff ET
Cancer J Sci Am; 1999; 5(5):266-8. PubMed ID: 10526666
[No Abstract] [Full Text] [Related]
10. The breast surgeon's role in BRCA1 and BRCA2 testing.
Matloff ET
Am J Surg; 2000 Oct; 180(4):294-8. PubMed ID: 11113439
[TBL] [Abstract][Full Text] [Related]
11. Cancer prevention, molecular genetics and hereditary cancer syndromes of colon and breast.
Lynch HT; Lynch JF
Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():27-32. PubMed ID: 9061291
[No Abstract] [Full Text] [Related]
12. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing.
Gayther SA; Ponder BA
Mol Med Today; 1997 Apr; 3(4):168-74. PubMed ID: 9134530
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing for breast cancer predisposition.
Gauthier-Villars M; Gad S; Caux V; Pagès S; Blandy C; Stoppa-Lyonnet D
Surg Clin North Am; 1999 Oct; 79(5):1171-87, xxi. PubMed ID: 10572557
[TBL] [Abstract][Full Text] [Related]
17. Breast & ovarian cancer. Issues in risk assessment.
Caro SW
Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
[No Abstract] [Full Text] [Related]
18. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
Sinclair CS; Berry R; Schaid D; Thibodeau SN; Couch FJ
Cancer Res; 2000 Mar; 60(5):1371-5. PubMed ID: 10728701
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer susceptibility genes. BRCA1 and BRCA2.
Brody LC; Biesecker BB
Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
[TBL] [Abstract][Full Text] [Related]
20. First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm.
Arver B; Borg A; Lindblom A
Genet Test; 2001; 5(1):1-8. PubMed ID: 11336395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]